|
Description: |
xii, 380 pages : illustrations |
|
|
Bibliography Note: |
Includes bibliographical references and index. |
|
|
Contents Note: |
Contents: Overview of vaccine strategies -- Designing vaccines in the era of genomics -- New analytical approaches for measuring protective capacity of antibodies -- New frontiers in the chemistry of glycoconjugate vaccines -- bacterial protein toxins used in vaccines -- Adjuvants -- Mucosal vaccines -- Intralymphatic vaccination -- The first vaccine obtained through reverse vaccinology: the serogroup B meningococcus vaccine -- Vaccines for neglected diseases -- Vaccines to combat pseudomonas aeruginosa infections in immunocompromised patients -- Nosocomial infections: Staphylococcus aureus -- Towards the development of a universal vaccine against group B streptococcus -- Vaccines against streptococcus pneumoniae -- Veterinary vaccines with a focus on bovine mastitis -- Vaccines against newly emerging viral diseases: the example of SARS. |